ADMA BIOLOGICS, INC. Uncategorized Contracts & Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934
ADMA BIOLOGICS, INC.
Biotechnology
2022
Open Market Sale AgreementSM, dated May 28, 2021, by and between ADMA Biologics, Inc. and Jefferies LLC
ADMA BIOLOGICS, INC.
Biotechnology
NY
2021
Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934
ADMA BIOLOGICS, INC.
Biotechnology
2021
Amendment No. 2 to Sale Agreement, dated as of February 3, 2021
ADMA BIOLOGICS, INC.
Biotechnology
NY
2021
Amendment to Open Market Sale AgreementSM, dated November 5, 2020, by and between ADMA Biologics, Inc. and Jefferies LLC
ADMA BIOLOGICS, INC.
Biotechnology
NY
2020
Open Market Sale AgreementSM, dated August 5, 2020, by and between ADMA Biologics, Inc. and Jefferies LLC
ADMA BIOLOGICS, INC.
Biotechnology
NY
2020
Agreement to Transfer Land, dated as of July 20, 2018, by and among Biotest Real Estate Corp., Biotest AG, Biotest Pharmaceuticals Corporation, ADMA BioManufacturing, LLC and ADMA...
ADMA BIOLOGICS, INC.
Biotechnology
FL
2018
Amendment #3 to the Manufacturing Agreement, effective as of December 21, 2017, by and between ADMA BioManufacturing, LLC and Sanofi Pasteur S.A
ADMA BIOLOGICS, INC.
Biotechnology
2018
Amendment #2 to the Manufacturing Agreement, effective as of August 1, 2016, by and between ADMA BioManufacturing, LLC (as successor-in-interest to Biotest Pharmaceuticals...
ADMA BIOLOGICS, INC.
Biotechnology
2018
Manufacturing Agreement, dated as of September 30, 2011, by and between ADMA BioManufacturing, LLC (as successor-in-interest to Biotest Pharmaceuticals Corporation) and Sanofi...
ADMA BIOLOGICS, INC.
Biotechnology
WA
2018
FOURTH AMENDMENT TO PLASMAPURCHASE AGREEMENT
ADMA BIOLOGICS, INC.
Biotechnology
2017
FIRST AMENDMENT TO LICENSEAGREEMENT
ADMA BIOLOGICS, INC.
Biotechnology
2017
PURCHASEAGREEMENT
ADMA BIOLOGICS, INC.
Biotechnology
GA
2017
PLASMAPURCHASE AGREEMENT NORMAL SOURCE PLASMA PURCHASEFROM BPC TO ADMA
ADMA BIOLOGICS, INC.
Biotechnology
DE
2017
TRANSITIONSERVICES AGREEMENT by and between ADMA BIOMANUFACTURING,LLC and BIOTEST PHARMACEUTICALSCORPORATION Dated as ofJune 6, 2017
ADMA BIOLOGICS, INC.
Biotechnology
DE
2017
STOCKHOLDERS AGREEMENT by and among ADMA Biologics, Inc., Biotest Pharmaceuticals Corporation and Such other Persons who become party heretopursuant to Section 4.1(c)...
ADMA BIOLOGICS, INC.
Biotechnology
NY
2017
Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 under the...
ADMA BIOLOGICS, INC.
Biotechnology
DE
2016
Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 under the...
ADMA BIOLOGICS, INC.
Biotechnology
2016
1,225,000Shares*
ADMA BIOLOGICS, INC.
Biotechnology
NY
2015
EQUITY RIGHTS LETTER
ADMA BIOLOGICS, INC.
Biotechnology
2013
ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***]
ADMA BIOLOGICS, INC.
Biotechnology
DE
2012
FORM OF LOCK-UP AGREEMENT
ADMA BIOLOGICS, INC.
Biotechnology
2012